Consistently rated amongst the world’s best universities, Imperial College London is a science- based institution with a reputation for excellence in teaching and research that attracts 14,000 students and 6,000 staff of the highest international quality. The Department of Stroke Medicine at Imperial College represents an integrated clinical and research structure that is dedicated to support clinical and translational research in acute stroke and stroke prevention. It is embedded in the Division of Brain Sciences at Imperial College London.
Imperial’s Programme Management Office (PMO) has over 20 years’ experience in the management of complex consortia, not only in EU funding programmes (such as FP6, FP7), but also with commercial bids and tenders from EU and UK awarding bodies.
Prof. Roland Veltkamp and the Stroke Research group at Imperial College London are the PRESTIGE-AF scientific consortium coordinator and clinical trial coordinator, respectively.
Imperial’s Programme Management Office (PMO) are the leads on consortium management and the consortium’s Dissemination, Communication and Exploitation activities.View All Partners